ASBMT Symposium Report - BMT REVIEWS
Transplantation for the Older Patient: More Choices for Improving Outcomes
This CME program was adapted from an NMDP sponsored symposium held prior to the 2005 ASH Annual Meeting on December 9, 2005, in Atlanta, Georgia.Blood and Marrow Transplantation Reviews
A Publication of the ASBMT. Issues in Hematology, Oncology, and Immunology Volume 16 Issue 2 2006Order a copy
Program Description
Transplantation is becoming widely accepted as an option for patients older than 50 years of age. These patients present different clinical scenarios than younger patients, but with appropriate decision-making in evaluation, treatment selection strategies, and supportive care, transplantation can be an effective option for older patients. This text focuses on the most recent outcomes data and provides practical considerations for evaluating and treating older patients who may benefit from transplantation.Faculty
Dennis L. Confer, MD, William B. Ershler, MD, Nelson J. Chao, MD, Edwin P. Alyea, MD, Stephen J. Forman, MD, Marcos J. de Lima, MDLearning Objectives
At completion of this activity, participants will be able to:- Identify factors to consider when evaluating an older patient for transplantation.
- Evaluate autologous vs. allogeneic donor options for transplantation.
- Compare goals and outcomes of myeloablative vs. reduced-intensity regimens.
- Describe patient selection criteria for transplantation for multiple myeloma, follicular lymphoma, and chronic lymphocytic leukemia in older patients.
- Describe patient selection criteria for transplantation for acute myelogenous leukemia and myelodysplastic syndromes in older patients.

